Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with rituximab-CHOP: a report from an International DLBCL Rituximab-CHOP Consortium Program study.

Xu Monette ZY;Wu L;Visco C;Tai YC;Tzankov A;Liu WM;Montes Moreno S;Dybkær K;Chiu A;Orazi A;Zu Y;Bhagat G;Richards KL;Hsi ED;Zhao XF;Choi WW;Zhao X;van Krieken JH;Huang Q;Huh J;Ai W;PONZONI , MAURILIO;Ferreri AJ;Zhou F;Kahl BS;Winter JN;Xu W;Li J;Go RS;Li Y;Piris MA;Møller MB;Miranda RN;Abruzzo LV;Medeiros LJ;Young K.H.

2012-01-01